Andrew Tsatsanis
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Synthesis, physicochemical characterization and neuroprotective evaluation of novel 1-hydroxypyrazin-2(1H)-one iron chelators in an in vitro cell model of Parkinson's disease.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: February 11, 2022
The acute phase protein lactoferrin is a key feature of Alzheimer's disease and predictor of Aβ burden through induction of APP amyloidogenic processing.
Journal: Molecular psychiatry
Published: February 22, 2021
Amyloidogenic processing of Alzheimer's disease β-amyloid precursor protein induces cellular iron retention.
Journal: Molecular psychiatry
Published: October 26, 2019
Changes in cortical protein markers of iron transport with gender, major depressive disorder and suicide.
Journal: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
Published: December 05, 2018
Post Translational Modulation of β-Amyloid Precursor Protein Trafficking to the Cell Surface Alters Neuronal Iron Homeostasis.
Journal: Neurochemical research
Published: November 07, 2018
Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelators.
Journal: Metallomics : integrated biometal science
Published: March 18, 2015
β-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin.
Journal: PloS one
Published: August 04, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026